Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

BIO-TECHNE (TECH) Operating Margin: 2009-2025

Historic Operating Margin for BIO-TECHNE (TECH) over the last 16 years, with Sep 2025 value amounting to 16.63%.

  • BIO-TECHNE's Operating Margin rose 282.00% to 16.63% in Q3 2025 from the same period last year, while for Sep 2025 it was 9.03%, marking a year-over-year decrease of 725.00%. This contributed to the annual value of 8.38% for FY2025, which is 945.00% down from last year.
  • BIO-TECHNE's Operating Margin amounted to 16.63% in Q3 2025, which was up 320.94% from -7.53% recorded in Q2 2025.
  • In the past 5 years, BIO-TECHNE's Operating Margin registered a high of 2,815.85% during Q3 2022, and its lowest value of -7.53% during Q2 2025.
  • Over the past 3 years, BIO-TECHNE's median Operating Margin value was 15.96% (recorded in 2024), while the average stood at 16.45%.
  • In the last 5 years, BIO-TECHNE's Operating Margin skyrocketed by 279,132bps in 2022 and then tumbled by 279,568bps in 2023.
  • BIO-TECHNE's Operating Margin (Quarterly) stood at 23.15% in 2021, then spiked by 184bps to 25.00% in 2022, then tumbled by 1,106bps to 13.94% in 2023, then skyrocketed by 202bps to 15.96% in 2024, then skyrocketed by 282bps to 16.63% in 2025.
  • Its last three reported values are 16.63% in Q3 2025, -7.53% for Q2 2025, and 12.24% during Q1 2025.